期刊文献+

Insulin like growth factor-1 increases fatty liver preservation in IGL-1 solution 被引量:7

Insulin like growth factor-1 increases fatty liver preservation in IGL-1 solution
下载PDF
导出
摘要 AIM: To investigate the benefits of insulin like growth factor-1 (IGF-1) supplementation to serum-free institut georges lopez-1 (IGL-1) solution to protect fatty liver against cold ischemia reperfusion injury. METHODS: Steatotic livers were preserved for 24 h in IGL-1  solution supplemented with or without IGF-1 and then perfused "ex vivo " for 2 h at 37℃. We examined the effects of IGF-1 on hepatic damage and function (transaminases, percentage of sulfobromophthalein clearance in bile and vascular resistance). We also studied other factors associated with the poor tolerance of fatty livers to cold ischemia reperfusion injury such as mitochondrial damage, oxidative stress, nitric oxide, tumor necrosis factor-α (TNF-α) and mitogen-activated protein kinases.RESULTS: Steatotic livers preserved in IGL-1 solutionsupplemented with IGF-1 showed lower transaminase levels, increased bile clearance and a reduction in vascular resistance when compared to those preserved in IGL-1solution alone. These benefits are mediated by activation of AKT and constitutive endothelial nitric oxide synthase (eNOS), as well as the inhibition of inflammatory cytokines such as TNF-α. Mitochondrial damage and oxidative stress were also prevented.CONCLUSION: IGL-1  enrichment with IGF-1 increasedfatty liver graft preservation through AKT and eNOS activation, and prevented TNF-α release during normothermic reperfusion. AIM: To investigate the benefits of insulin like growth factor-1 (IGF-1) supplementation to serum-free institut georges lopez-1 (IGL-1) solution to protect fatty liver against cold ischemia reperfusion injury. METHODS: Steatotic livers were preserved for 24 h in IGL-1  solution supplemented with or without IGF-1 and then perfused 'ex vivo ' for 2 h at 37℃. We examined the effects of IGF-1 on hepatic damage and function (transaminases, percentage of sulfobromophthalein clearance in bile and vascular resistance). We also studied other factors associated with the poor tolerance of fatty livers to cold ischemia reperfusion injury such as mitochondrial damage, oxidative stress, nitric oxide, tumor necrosis factor-α (TNF-α) and mitogen-activated protein kinases.RESULTS: Steatotic livers preserved in IGL-1 solutionsupplemented with IGF-1 showed lower transaminase levels, increased bile clearance and a reduction in vascular resistance when compared to those preserved in IGL-1solution alone. These benefits are mediated by activation of AKT and constitutive endothelial nitric oxide synthase (eNOS), as well as the inhibition of inflammatory cytokines such as TNF-α. Mitochondrial damage and oxidative stress were also prevented.CONCLUSION: IGL-1  enrichment with IGF-1 increasedfatty liver graft preservation through AKT and eNOS activation, and prevented TNF-α release during normothermic reperfusion.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2010年第45期5693-5700,共8页 世界胃肠病学杂志(英文版)
基金 Supported by The Ministry of Health and Consumption(PI081988),CIBER-ehd,Carlos Ⅲ Institute,Madrid,Spain Ministry of Foreign Affairs and International Cooperation(A/020255/08and A/02987/09) Mohamed Amine Zaouali is fellowship-holder from the Catalan Society of Transplantation
关键词 AKT Institut georges lopez-1 SOLUTION Insulin like growth factor-1 Ischemia REPERFUSION injury NITRIC oxide Oxidative stress Steatotic GRAFT PRESERVATION AKT Institut georges lopez-1 solution Insulin like growth factor-1 Ischemia reperfusion injury Nitric oxide Oxidative stress Steatotic graft preservation
  • 相关文献

参考文献53

  • 1Hassen Ben Abdennebi,Ziad Elrassi,Jean-Yves Scoazec,Jean-Paul Steghens,Silvina Ramella-Virieux,Olivier Boillot.Evaluation of IGL-1 preservation solution using an orthotopic liver transplantation model[J].World Journal of Gastroenterology,2006,12(33):5326-5330. 被引量:5
  • 2Ramalho FS,,Fernandez-Monteiro I,Rosello-Catafau J,Per-alta C.Hepatic microcirculatory failure. Acta Cir Bras . 2006
  • 3El-Gibaly AM,Scheuer C,Menger MD,Vollmar B.Improve-ment of rat liver graft quality by pifithrin-alpha-mediatedinhibition of hepatocyte necrapoptosis. Hepatology . 2004
  • 4Franco-Gou R,Mosbah IB,Serafin A,Abdennebi HB,Roselló-Catafau J,Peralta C.New preservation strategies for prevent-ing liver grafts against cold ischemia reperfusion injury. Journal of Gastroenterology and Hepatology . 2007
  • 5Ben Mosbah I,Roselló-Catafau J,Franco-Gou R,AbdennebiHB,Saidane D,Ramella-Virieux S,Boillot O,Peralta C.Pres-ervation of steatotic livers in IGL-1solution. Liver Transplantation . 2006
  • 6Kuriyama N,Isaji S,Hamada T,Kishiwada M,Ohsawa I,Usui M,Sakurai H,Tabata M,Hayashi T,Suzuki K.Thecytoprotective effects of addition of activated protein C intopreservation solution on small-for-size grafts in rats. Liver Transplantation . 2010
  • 7Laroux FS,Pavlick KP,Hines IN,Kawachi S,Harada H,Bharwani S,Hoffman JM,Grisham MB.Role of nitric oxidein inflammation. Acta Physiologica Scandinavica . 2001
  • 8García-Fernández M,Castilla-Cortázar I,Díaz-SanchezM,Navarro I,Puche JE,Castilla A,Casares AD,Clavijo E,González-Barón S.Antioxidant effects of insulin-like growthfactor-I(IGF-I)in rats with advanced liver cirrhosis. BMCGastroenterol . 2005
  • 9Casillas-Ramírez A,Zaouali A,Padrissa-Altés S,Ben Mos-bah I,Pertosa A,Alfany-Fernández I,Bintanel-MorcilloM,Xaus C,Rimola A,Rodés J,Roselló-Catafau J,PeraltaC.Insulin-like growth factor and epidermal growth factortreatment:new approaches to protecting steatotic liversagainst ischemia-reperfusion injury. The Journal of Endocrinology . 2009
  • 10Conti E,Carrozza C,Capoluongo E,Volpe M,Crea F,Zup-pi C,Andreotti F.Insulin-like growth factor-1as a vascularprotective factor. Circulation . 2004

二级参考文献52

  • 1YingCheng Yong-FengLiu Dong-HuaCheng Bai-FengLi NingZhao.Evaluation of CMU-1 preservation solutions using an isolated perfused rat liver model[J].World Journal of Gastroenterology,2005,11(16):2522-2525. 被引量:1
  • 2[1]Todo S,Demetris AJ,Makowka L,Teperman L,Podesta L,Shaver T,Tzakis A,Starzl TE.Primary nonfunction of hepatic allografts with preexisting fatty infiltration.Transplantation1989; 47:903-905
  • 3[2]Imber CJ,St Peter SD,Handa A,Friend PJ.Hepatic steatosis and its relationship to transplantation.Liver Transpl 2002; 8:415-423
  • 4[3]Selzner M,Clavien PA.Fatty liver in liver transplantation and surgery.Semin Liver Dis 2001; 21:105-113
  • 5[4]Todo S,Nery J,Yanaga K,Podesta L,Gordon RD,Starzl TE.Extended preservation of human liver grafts with UW solution.JAMA 1989; 261:711-714
  • 6[5]Stratta RJ,Wood RP,Langnas AN,Duckworth RM,Markin RS,Marujo W,Grazi GL,Saito S,Dawidson I,Rikkers LF.The impact of extended preservation on clinical liver transplantation.Transplantation 1990; 50:438-443
  • 7[6]El-Gibaly AM,Scheuer C,Menger MD,Vollmar B.Improvement of rat liver graft quality by pifithrin-alpha-mediated inhibition of hepatocyte necrapoptosis.Hepatology 2004; 39:1553-1562
  • 8[7]Klar E,Angelescu M,Zapletal C,Kraus T,Bredt M,Herfarth C.Definition of maximum cold ischemia time without reduction of graft quality in clinical liver transplantation.Transplant Proc 1998; 30:3683-3685
  • 9[8]Ikizler M,Dernek S,Sevin B,Kural T.Trimetazidine improves recovery during reperfusion in isolated rat hearts after prolonged ischemia.Anadolu Kardiyol Derg 2003; 3:303-308
  • 10[9]Veitch K,Maisin L,Hue L.Trimetazidine effects on the damage to mitochondrial functions caused by ischemia and reperfusion.Am J Cardiol 1995; 76:25B-30B

共引文献8

同被引文献68

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部